Armenian SH, Lacchetti C, Barac A, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers : American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2017 ; 35 : 893.
Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy : clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 2010 ; 55 : 213.
Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 2015 ; 131 : 1981.
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al ; ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016 ; 37 : 2768.
Curigliano G, Lenihan D, Fradley M, et al ; ESMO Guidelines Committee. Electronic address : clinicalguidelines@esmo.org. Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations. Ann Oncol 2020 ; 31 : 171.